Verano Holdings (VRNO) Intangibles (2021 - 2026)
Verano Holdings' (VRNO) quarterly Intangibles came in at $564.6 million in Q1 2026, down 21.29% year-on-year from $717.3 million in Q1 2025, and down 2.51% on a QoQ basis from $579.1 million in Q4 2025.
Verano Holdings (VRNO) Intangibles (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Intangibles data on file, last reported at $564.6 million in Q1 2026.
- On a quarterly basis, Intangibles fell 21.29% year-over-year to $564.6 million in Q1 2026; TTM through Mar 2026 was $564.6 million, a 21.29% decrease from a year earlier, with the FY2025 full-year figure at $579.1 million, down 21.11% from the prior year.
- Intangibles for Q1 2026 stood at $564.6 million, down from $579.1 million in the prior quarter.
- Over the last five years, Intangibles for VRNO reached as high as $1.3 billion in Q2 2022 and fell as low as $564.6 million in Q1 2026.
- Historically, Intangibles has averaged $967.2 million across 5 years, with a median of $1.1 billion in 2024.
- Across the five-year window, Intangibles jumped 176659.34% in 2022 and plunged 34.72% in 2025, its largest moves.
- Year by year, Intangibles stood at $1.2 billion in 2022, then fell by 8.01% to $1.1 billion in 2023, then plunged by 32.42% to $734.0 million in 2024, then slipped by 21.11% to $579.1 million in 2025, then slipped by 2.51% to $564.6 million in 2026.
- Per Business Quant data, the three most recent Intangibles figures were $564.6 million in Q1 2026, $579.1 million in Q4 2025, and $683.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | 5.29 Mn |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Verano Holdings | 2.00 Bn | 1.92 Bn | 98.98 Mn | 564.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 564.58 Mn |
| Dec 31, 2025 | 579.09 Mn |
| Sep 30, 2025 | 683.77 Mn |
| Jun 30, 2025 | 700.52 Mn |
| Mar 31, 2025 | 717.26 Mn |
| Dec 31, 2024 | 734.01 Mn |
| Sep 30, 2024 | 1.05 Bn |
| Jun 30, 2024 | 1.04 Bn |
| Mar 31, 2024 | 1.06 Bn |
| Dec 31, 2023 | 1.09 Bn |
| Sep 30, 2023 | 1.11 Bn |
| Jun 30, 2023 | 1.14 Bn |
| Mar 31, 2023 | 1.16 Bn |
| Dec 31, 2022 | 1.18 Bn |
| Sep 30, 2022 | 1.33 Bn |
| Jun 30, 2022 | 1.34 Bn |
| Dec 31, 2021 | 1.38 Bn |
| Jun 30, 2021 | 760,000.00 |